Valo Therapeutics
PrivateLast Round
VC Round
Mar 10, 2025
Total Funding Raised
$24.37M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Valo Therapeutics is a biotechnology company that develops novel immunotherapies for cancer and infectious diseases using its proprietary PeptiCRAd platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valo Therapeutics Comparables
Compare Valo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TILT Biotherapeutics | 89% | |
| Nouscom | 83% | |
| Accession Therapeutics Limited | 82% |
Valo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 10, 2025 | ||||
| Grant | Feb 14, 2023 | ||||
| Private Equity | Nov 15, 2021 | ||||
| Seed | Feb 6, 2020 | ||||
| Debt | Jul 4, 2017 | ||||
Seed | Jan 1, 2017 |
Key People
Founding team and executive leadership
Valo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Freeman Road | VC Round |
| European Innovation Council Fund | Grant |
| Indaco Venture Partners SGR | VC Round |
| CDP Venture Capital SGR | VC Round |
| Tekes | Debt |
| ENEA-Tech and Biomedical Foundation | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 34% MoM, from 674 to 900.
- Apr 9, 2025
Marcella Origgi joins as the new CEO, coming from Johnson & Johnson Innovation.
Valo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Valo Therapeutics's valuation, stock price, and market status.
Is Valo Therapeutics a public or private company?
Valo Therapeutics is a private company.
What is the current stock price of Valo Therapeutics?
Valo Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Valo Therapeutics worth (valuation)?
Valuation information for Valo Therapeutics is not publicly available.
Can I buy Valo Therapeutics stock?
Valo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Valo Therapeutics's last funding round?
Valo Therapeutics's most recent funding round was Early Funding on March 10, 2025.
Who are the main investors in Valo Therapeutics?
Key investors in Valo Therapeutics include Indaco Venture Partners SGR, CDP Venture Capital SGR.
Will Valo Therapeutics IPO soon?
No public IPO plans have been announced for Valo Therapeutics.
How can I track Valo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Valo Therapeutics's secondary market activity and sign up for updates.